Q3 2021 |
83 |
$122M |
+$9.04M |
-$2.86M |
+$6.18M |
IVV, LMBS, MSFT, IWR, IWF
|
13F-HR |
11/12/2021, 10:38 AM |
Q2 2021 |
81 |
$116M |
+$8.36M |
-$14.8M |
-$6.41M |
IVV, LMBS, MSFT, IWR, IWF
|
13F-HR |
8/13/2021, 02:50 PM |
Q1 2021 |
82 |
$116M |
+$6.06M |
-$19M |
-$13M |
IVV, LMBS, MSFT, IWR, IWF
|
13F-HR |
5/17/2021, 03:34 PM |
Q4 2020 |
98 |
$119M |
+$6.81M |
-$83.1M |
-$76.3M |
IVV, GDXJ, LMBS, MSFT, IWF
|
13F-HR |
2/16/2021, 04:21 PM |
Q3 2020 |
114 |
$179M |
+$17.8M |
-$19.4M |
-$1.57M |
AAPL, IVV, GDXJ, LMBS, MSFT
|
13F-HR |
11/16/2020, 03:25 PM |
Q2 2020 |
114 |
$181M |
+$8.84M |
-$49.8M |
-$40.9M |
AAPL, GDXJ, IVV, MSFT, LMBS
|
13F-HR |
8/14/2020, 05:11 PM |
Q1 2020 |
114 |
$190M |
+$70.2M |
-$50.4M |
+$19.9M |
AAPL, IVV, JNJ, MSFT, JPM
|
13F-HR |
5/15/2020, 05:16 PM |
Q4 2019 |
91 |
$217M |
+$18.2M |
-$18.8M |
-$611K |
AAPL, IVV, GSK, PPL, INTC
|
13F-HR |
2/14/2020, 03:44 PM |
Q3 2019 |
92 |
$200M |
+$10.7M |
-$32.7M |
-$21.9M |
AAPL, IVV, GSK, PPL, MET
|
13F-HR |
11/14/2019, 09:57 AM |
Q2 2019 |
97 |
$218M |
+$32.4M |
-$19.3M |
+$13.1M |
AAPL, IWF, MET, IVV, PPL
|
13F-HR |
8/13/2019, 10:56 AM |
Q1 2019 |
98 |
$201M |
+$28.3M |
-$24.5M |
+$3.79M |
IWF, GSK, PPL, IVV, MET
|
13F-HR |
5/13/2019, 12:11 PM |
Q4 2018 |
99 |
$179M |
+$41.5M |
-$34.7M |
+$6.8M |
IWD, MSFT, IWF, INTC, GSK
|
13F-HR |
2/13/2019, 05:40 PM |
Q3 2018 |
119 |
$196M |
+$13.5M |
-$30.3M |
-$16.8M |
MSFT, CVX, JPM, IVV, GSK
|
13F-HR |
11/14/2018, 09:12 AM |
Q2 2018 |
131 |
$201M |
+$13.4M |
-$32.5M |
-$19.1M |
CVX, MSFT, AMZN, PNC, JPM
|
13F-HR |
8/14/2018, 07:02 AM |
Q1 2018 |
138 |
$220M |
+$24.1M |
-$27M |
-$2.9M |
MSFT, CVX, INTC, PNC, JPM
|
Restatement |
5/15/2018, 09:58 PM |
Q4 2017 |
135 |
$223M |
+$31.1M |
-$16.1M |
+$15M |
INTC, MSFT, CVX, PNC, GVI
|
13F-HR |
2/12/2018, 09:49 PM |
Q3 2017 |
132 |
$200M |
+$28.8M |
-$10.9M |
+$17.9M |
MSFT, CVX, INTC, SPY, VNQ
|
13F-HR |
11/13/2017, 07:59 AM |
Q2 2017 |
122 |
$175M |
+$9.41M |
-$8.66M |
+$744K |
MSFT, CVX, INTC, PNC, IWF
|
13F-HR |
8/14/2017, 10:14 AM |
Q1 2017 |
127 |
$171M |
+$45.9M |
-$20.8M |
+$25M |
MSFT, INTC, VTEB, CVX, PNC
|
13F-HR |
5/12/2017, 05:47 PM |
Q4 2016 |
125 |
$142M |
$0 |
$0 |
|
GBF, VTEB, MSFT, GVI, VNQ
|
13F-HR |
2/14/2017, 07:38 PM |